Relationship between hyperlipidemia, lipid mediators, and progressive glomerulosclerosis in the nephrotic syndrome

Deborah Kees-Folts, Jonathan R. Diamond

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Nephrotic syndrome is defined by proteinuria, hypoalbuminemia, edema and hypercholesterolemia. Evidence from both the experimental and clinical literature suggests that high lipid levels are not only a marker of disease, but also contribute to the process of glomerulosclerosis. Lipid mediators, including eicosanoids, platelet-activating factor, and chemotactic factors, can contribute by effecting leukocyte infiltration, mesangial proliferation, extracellular matrix protein production, vasoreactivity, and coagulation. Infiltrating macrophages may play a central role in these processes. Therapeutic maneuvers aimed at the correction of lipid abnormalities may halt or slow the progression of nephrotic syndrome to end-stage renal disease.

Original languageEnglish (US)
Pages (from-to)365-375
Number of pages11
JournalAmerican Journal of Nephrology
Volume13
Issue number5
DOIs
StatePublished - Jan 1 1993

Fingerprint

Nephrotic Syndrome
Hyperlipidemias
Lipids
Glomerular Mesangium
Hypoalbuminemia
Eicosanoids
Extracellular Matrix Proteins
Platelet Activating Factor
Chemotactic Factors
Hypercholesterolemia
Proteinuria
Chronic Kidney Failure
Edema
Leukocytes
Macrophages
Therapeutics

All Science Journal Classification (ASJC) codes

  • Nephrology

Cite this

@article{c75d70481fb04ba49ee5fec77b9fe380,
title = "Relationship between hyperlipidemia, lipid mediators, and progressive glomerulosclerosis in the nephrotic syndrome",
abstract = "Nephrotic syndrome is defined by proteinuria, hypoalbuminemia, edema and hypercholesterolemia. Evidence from both the experimental and clinical literature suggests that high lipid levels are not only a marker of disease, but also contribute to the process of glomerulosclerosis. Lipid mediators, including eicosanoids, platelet-activating factor, and chemotactic factors, can contribute by effecting leukocyte infiltration, mesangial proliferation, extracellular matrix protein production, vasoreactivity, and coagulation. Infiltrating macrophages may play a central role in these processes. Therapeutic maneuvers aimed at the correction of lipid abnormalities may halt or slow the progression of nephrotic syndrome to end-stage renal disease.",
author = "Deborah Kees-Folts and Diamond, {Jonathan R.}",
year = "1993",
month = "1",
day = "1",
doi = "10.1159/000168651",
language = "English (US)",
volume = "13",
pages = "365--375",
journal = "American Journal of Nephrology",
issn = "0250-8095",
publisher = "S. Karger AG",
number = "5",

}

Relationship between hyperlipidemia, lipid mediators, and progressive glomerulosclerosis in the nephrotic syndrome. / Kees-Folts, Deborah; Diamond, Jonathan R.

In: American Journal of Nephrology, Vol. 13, No. 5, 01.01.1993, p. 365-375.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Relationship between hyperlipidemia, lipid mediators, and progressive glomerulosclerosis in the nephrotic syndrome

AU - Kees-Folts, Deborah

AU - Diamond, Jonathan R.

PY - 1993/1/1

Y1 - 1993/1/1

N2 - Nephrotic syndrome is defined by proteinuria, hypoalbuminemia, edema and hypercholesterolemia. Evidence from both the experimental and clinical literature suggests that high lipid levels are not only a marker of disease, but also contribute to the process of glomerulosclerosis. Lipid mediators, including eicosanoids, platelet-activating factor, and chemotactic factors, can contribute by effecting leukocyte infiltration, mesangial proliferation, extracellular matrix protein production, vasoreactivity, and coagulation. Infiltrating macrophages may play a central role in these processes. Therapeutic maneuvers aimed at the correction of lipid abnormalities may halt or slow the progression of nephrotic syndrome to end-stage renal disease.

AB - Nephrotic syndrome is defined by proteinuria, hypoalbuminemia, edema and hypercholesterolemia. Evidence from both the experimental and clinical literature suggests that high lipid levels are not only a marker of disease, but also contribute to the process of glomerulosclerosis. Lipid mediators, including eicosanoids, platelet-activating factor, and chemotactic factors, can contribute by effecting leukocyte infiltration, mesangial proliferation, extracellular matrix protein production, vasoreactivity, and coagulation. Infiltrating macrophages may play a central role in these processes. Therapeutic maneuvers aimed at the correction of lipid abnormalities may halt or slow the progression of nephrotic syndrome to end-stage renal disease.

UR - http://www.scopus.com/inward/record.url?scp=0027762720&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027762720&partnerID=8YFLogxK

U2 - 10.1159/000168651

DO - 10.1159/000168651

M3 - Article

C2 - 8116689

AN - SCOPUS:0027762720

VL - 13

SP - 365

EP - 375

JO - American Journal of Nephrology

JF - American Journal of Nephrology

SN - 0250-8095

IS - 5

ER -